Molecular cytogenetic characterisation of a novel de novo ring chromosome 6 involving a terminal 6p deletion and terminal 6q duplication in the different arms of the same chromosome by Pace, Nikolai Paul et al.
CASE REPORT Open Access
Molecular cytogenetic characterisation of a
novel de novo ring chromosome 6
involving a terminal 6p deletion and
terminal 6q duplication in the different
arms of the same chromosome
Nikolai Paul Pace1, Frideriki Maggouta2, Melissa Twigden2 and Isabella Borg1,3,4*
Abstract
Background: Ring chromosome 6 is a rare sporadic chromosomal abnormality, associated with extreme variability
in clinical phenotypes. Most ring chromosomes are known to have deletions on one or both chromosomal arms. Here,
we report an atypical and unique ring chromosome 6 involving both a distal deletion and a distal duplication on the
different arms of the same chromosome.
Case presentation: In a patient with intellectual disability, short stature, microcephaly, facial dysmorphology, congenital
heart defects and renovascular disease, a ring chromosome 6 was characterised using array-CGH and dual-colour FISH.
The de-novo ring chromosome 6 involved a 1.8 Mb terminal deletion in the distal short arm and a 2.5 Mb duplication in
the distal long arm of the same chromosome 6. This results in monosomy for the region 6pter to 6p25.3 and trisomy for
the region 6q27 to 6qter. Analysis of genes in these chromosomal regions suggests that haploinsufficiency for FOXC1
and GMDS genes accounts for the cardiac and neurodevelopmental phenotypes in the proband. The ring chromosome
6 reported here is atypical as it involves a unique duplication of the distal long arm. Furthermore, the presence of
renovascular disease is also a unique feature identified in this patient.
Conclusion: To the best of our knowledge, a comparable ring chromosome 6 involving both a distal deletion
and duplication on different arms has not been previously reported. The renovascular disease identified in this
patient may be a direct consequence of the described chromosome rearrangement or a late clinical presentation in r(6)
cases. This clinical finding may further support the implicated role of FOXC1 gene in renal pathology.
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Background
Constitutional ring chromosomes are rare sporadic
chromosomal abnormalities and can involve any of the
22 pairs of autosomes as well as the sex chromosomes.
They arise from breaks in the two arms of a chromo-
some, followed by fusion of the two broken ends or of
one broken end with the opposite telomere region [1].
Alternatively, two dysfunctional telomeres from the
same chromosome fuse, resulting in the formation of a
complete ring with no deletions. The clinical phenotype
associated with ring chromosomes is highly variable, de-
pending on the extent of the deletion and the chromo-
some involved.
Ring chromosome 6 is a rare sporadic chromosomal
abnormality, first described by Moore et al in 1973 in a
female infant who exhibited varying dysmorphic features
[2]. The phenotypic features are very variable and range
from an almost normal phenotype to severe malforma-
tions and intellectual disability. Peeden et al reviewed
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the variability of phenotypic features in 14 cases of ring
chromosome 6 [3]. The most frequent clinical features
include failure to thrive, congenital heart defects, intel-
lectual disability, microcephaly and facial dysmorphology
[4]. Also reported are various abnormalities in the ocu-
lar, auditory and central nervous systems.
We report a unique de novo ring chromosome 6 char-
acterised by array-CGH and FISH involving a deletion in
the distal short arm and a duplication in the distal long
arm of the same chromosome.
Case presentation
The proband was referred to the genetics clinic at the age
of 49 years, during a hospital admission for a chest infec-
tion. He is the 4th in a sibship of 5 offspring of non-
consanguineous Caucasian parents. He was born by normal
vaginal delivery following an uneventful term pregnancy.
At birth he was found to have a small atrial septal defect.
He was a slow feeder and early motor, cognitive and devel-
opmental milestones were delayed. At the age of 10 years
he was diagnosed with bilateral hearing loss which wors-
ened progressively. A CT scan of the brain performed at
the age of 21 years, revealed the presence of a Dandy
Walker variant, normal internal auditory maeti and a nor-
mal sella turcica. His medical history also includes chronic
venous insufficiency and hypertension. The parents gave
no relevant family history.
Physical examination at the genetics clinic revealed an
adult male with moderate intellectual disability, short
stature (height of 141 cms) and microcephaly (head cir-
cumference of 51.6 cms). Dysmorphic features included
a right-sided hair whorl, a small nose, a high arched pal-
ate, a nuchal hump, mild scoliosis, brachydactyly and
overlapping toes on the left foot. The skin was very dry
and there was considerable venous insufficiency of the
lower limbs.
An echocardiogram revealed borderline concentric left
ventricular hypertrophy, mild right ventricular hyper-
trophy, a patent foramen ovale and a very small atrial sep-
tal defect, for which he subsequently underwent cardiac
surgery. Blood investigations revealed renal pathology but
renal imaging was unremarkable. Subsequently a renal bi-
opsy revealed long-standing renovascular disease but no
vasculitis.
Methods
Array comparative genomic hybridisation (array-CGH)
was performed at the Wessex Regional Genetics Labora-
tory using an Oxford Gene Technology (OGT, Oxford,
UK) CytosureTM Constitutional v3 custom 8x60K oligo
array, manufactured by Agilent Technologies [Agilent
Technologies, Santa Clara, CA].
Dual-colour fluorescence in situ hybridisation (FISH)
was performed with 2 bacterial artificial chromosomes
(BACs) chosen from the Sanger 30K cloneset using the
Ensembl genome browser (http://www.ensembl.org/
Homo_sapiens/) together with the chromosome 6 spe-
cific centromere probe, D6Z1. The probes used were the
6p25.3 specific BAC, RP11-13J16 (GRCh37 bp 1296996
– 1357295) and the 6q27 specific BAC, RP11-417E7
(GRCh37 bp 169417007 – 16959015).
Results
Array CGH identified an approximately 1.8 Mb terminal
deletion involving the distal short arm of a chromosome
6, with the breakpoint within a 68kb interval in 6p25.3
(arr(GRCh37) 6p25.3(164360_1773695)x1) (Fig. 1a). The
array also detected an approximately 2.5 Mb duplication
involving the distal long arm of a chromosome 6, with the
breakpoint within a 125kb interval in 6q27 (arr(GRCh37)
6q27(168682830_170923504)x3) (Fig. 1b). The proband is,
therefore, monosomic for the region 6pter to 6p25.3 and
trisomic for the region 6q27 to 6qter.
To characterise the imbalances further and to determine
whether they occurred in cis or trans, FISH studies were
undertaken on peripheral blood metaphase chromosomes
from the proband and both his parents using the 6p25.3
specific BAC RP11-13J16 and the 6q27 specific BAC
RP11-417E7 as well as a 6 centromere probe (D6Z1).
FISH confirmed both the 6p deletion and 6q duplica-
tion identified by array-CGH and showed that the imbal-
ances are present in the form of a ring chromosome 6,
r(6), which replaces a normal chromosome 6. The r(6)
was shown to be monocentric, deleted for the short arm
of 6p (6p25.3) and duplicated for the distal long arm of
6q (6q27) (Fig. 2). This r(6) represents an atypical and
unique ring chromosome in that the duplicated material
is located in a different arm of the chromosome to that
of the deleted material. FISH studies on both parents
showed that they had two normal chromosomes 6 and
therefore the r(6) had arisen de novo in the proband.
Discussion
Ring chromosome 6 is an exceptionally rare cytogenetic
rearrangement that usually arises de novo and is associ-
ated with extreme inter-individual variability in clinical
phenotypes. A number of reports have described the
clinical features in r(6) patients. However, to our know-
ledge this is the first case of r(6) involving both a distal
6p deletion and a distal 6q duplication.
At least two case reports have described a r(6) involv-
ing a comparable deletion at 6p25.3 [4, 5]. Both patients
had psychomotor delay, cerebral ventriculomegaly, a
prominent forehead and malformed ears. Furthermore,
Zhang et al report a deletion of identical size to the
present case (1.78Mb at 6p25.3) and additional clinical
features that include, microcephaly, hydrocephalus, epi-
lepsy and hearing loss [5].
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Fig. 2 FISH with the chromosome 6 specific centromere probe D6Z1 (green signal), the 6p25.3 BAC RP11-13J16 (a; red signal), and the 6q27 BAC
RP11-417E7 (b; red signal) showing a monocentric r(6) chromosome (arrow) with (a) 6p deletion and (b) 6q duplication
a b
Fig. 1 Array-CGH plots, analysed using Oxford Gene Technology (OGT) CytosureTM Constitutional v3 oligo array, showing. a the 1.8 Mb terminal
6p25.3 deletion with a log2 ratio of -1.0 at genomic coordinates 164360_1773695 (NCBI build 37, February 2009, hg19) and (b) the 2.5 Mb 6q27
duplication with a log2 ratio of +0.58 at genomic coordinates 168682830_170923504 (deleted/duplicated regions circled on chromosome 6 ideogram
and magnified and highlighted in main image as indicated by an arrow)
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Submicroscopic deletions involving the 6p25 subtelo-
meric region is a distinct clinical syndrome. The clinical
phenotypes described include developmental delay, intel-
lectual disability, language impairment, hearing loss, and
various ophthalmic, cardiac and craniofacial anomalies
[6]. As the clinical phenotypes observed in ring chromo-
somes overlap with those of deletion of one or both ends
of the respective chromosome syndromes, we explored
karyotype-phenotype associations by reviewing literature
that describes the function of genes located in the 6p25
and 6q27 regions.
A number of genes located in the 6p25-pter deletion
interval have OMIM entries, namely DUSP22, IRF4,
EXOC2, HUS1B, FOXQ1, FOXF2, FOXCUT, FOXC1 and
GMDS, as well as a number of uncharacterised genes.
Of these, IRF4 and FOXC1 are human disease genes.
Interferon regulatory factor 4 (IRF4) is a transcription
factor essential for the development of T helper 2 (Th2),
Th17 and Th9 cells, and the rs872071 variant in its 3-
prime untranslated region is a susceptibility locus for
chronic lymphocytic leukemia [7]. IRF4 is also required
for hair, skin and eye pigmentation [8].
The forkhead gene cluster at the 6p25.3-pter region
includes FOXQ1, FOXF2, FOXCUT and FOXC1 genes.
These transcription factors are essential for development
and morphogenesis. FOXC1 and FOXC2 genes are
expressed during cardiac development, and mutations in
these genes have been associated with a wide range of
cardiac abnormalities [9]. Zhang et al suggest that the
congenital cardiac anomalies observed in r(6) is due to
haploinsufficiency of FOXC1 [5].
Developmental delay and varying degrees of neuro-
logical defects are consistent features in 6p25 deletion
syndromes. FOXC1, FOXF2 and GMDS are involved in
central nervous system development and function. Animal
studies have shown that mice homozygous for a null allele
of Mf1 (the murine homolog of FOXC1) show congenital
hydrocephalus and eye defects [10]. Haploinsufficiency for
FOXC1 has been associated with hydrocephalus in
humans [6]. Abnormalities in the posterior cranial fossa,
including Dandy-Walker malformation, mega-cisterna
magna and cerebellar vermis hypoplasia have also been as-
sociated with homozygous FOXC1 mutations [11]. Any
deviation from normal FOXC1 gene dosage results in cen-
tral nervous system (CNS) vascular anomalies. Similarly,
FOXQ1 gene mediates neurite growth and neuronal
differentiation [12]. FOXF2 is expressed in murine peri-
cytes, and FOXF2 knockout mice develop intracranial
hemorrhage, perivascular oedema and a leaky blood-brain
barrier, further highlighting the role of these transcription
factors in CNS development and function [13].
The GMDS gene encodes GDP-mannose 4,6-dehydra-
tase, an enzyme that catalyzes the first step in protein
fucosylation. This is an essential post translational
modification in members of the Notch family of trans-
membrane receptors [12]. Notch signaling is essential
for neuronal and glial cell differentiation, maturation,
learning and memory. Song et al have described a zebra-
fish model that harbours a missense mutation in GMDS
resulting in defective fucosylation of Notch receptors
that leads to defects in neuronal development and syn-
apse branching [13]. These studies strongly suggest that
the varying degree of intellectual disability observed in
r(6) cases is due to haploinsufficiency of the FOXC1 and
GMDS genes. Further evidence supporting the role of
these two genes in neuronal function is provided by Hock-
ner et al [14]. Here, the authors describe a case of de-novo
r(6) in a 25-year-old female with short stature and only
minor dysmorphic features, but with normal psychomotor
development. Cytogenetic analysis had identified a 6p
breakpoint telomeric to the DUSP22 gene, with no disrup-
tion of either FOXC1 or GMDS coding sequences at 6p.
The short stature in this case report was attributed to mi-
totic instability of the ring chromosome.
The 6q duplication interval contains at least ten OMIM
genes, of which four have OMIM Morbid entries (SMOC2,
THBS2, ERMARD and TBP). Burnside et al report exten-
sive CNS developmental abnormalities in a two-month old
infant with a duplication of THBS2. This gene encodes
thrombospondin 2, an astrocyte-secreted protein essential
for synaptogenesis and neurite growth [15].
The r(6) outlined in this report is atypical in that no
functional genetic material from the long arm has been
lost, but material from the distal long arm (6q27) has been
duplicated. Guilherme et al studied breakpoints and mech-
anisms of ring formation in fourteen cases of ring chromo-
somes, and reported two cases of ring chromosome 13
where terminal deletions of 13q were associated with du-
plications near the breakpoints on the same chromosome
arm [1]. Similarly, Knijnenburg et al describe a case of ring
chromosome 14 shown to have a terminal 14q32.33 dele-
tion and an inverted duplication of 14q32.12 to 14q32.32
[16]. Comparably, Rossi et al investigated 33 probands
with ring chromosomes using both array-CGH and FISH,
and identified seven cases where duplications were also de-
tected in ring chromosomes 13, 15, 18, 21 and 22 [17]. It
is unusual for the duplicated material to be located on a
different arm of the chromosome to that of the deletion.
No similar findings involving ring chromosome 6 have
been reported in the literature. However, additional vari-
ants and imbalances of ring chromosome 6 have been de-
scribed. In a male infant with a number of dysmorphic
features and a large patent ductus arteriosus, Lee et al re-
port a mosaic karyotype with a dicentric ring chromosome
(46, XY, r(6)(p25q27)/46, XY, dic r(6;6)(p25q27;p25q27)
[18]. Birnbacher et al report a r(6) with an 6q26-qter dele-
tion and no 6p subtelomeric deletion, and Nishigaki et al a
similar r(6) with a 1.5Mb deletion at 6q27 [19, 20].
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The clinical features described in this proband, in par-
ticular the cardiac and neurological anomalies are largely
in common with other case reports of r(6). Haploinsuffi-
ciency for the forkhead gene cluster at 6p appears to be
the major driver leading to development of these fea-
tures. Of particular interest is the renovascular disease
finding reported in this proband. While FOXC1 disrup-
tion has been implicated in congenital anomalies of the
kidney and urinary tract in both animal and human
models, there is no reported link between this gene and
the development of renovascular disease [21]. Renovas-
cular disease was not described in any of the published
r(6) patients. This may suggest that either this is a direct
consequence of the unique r(6) presented here or that
this is a late onset clinical feature. It may therefore be
advisable to screen r(6) patients for renal pathology.
Conclusion
This report provides a detailed characterisation of a
novel r(6), involving a distal deletion at 6p25.3 and a dis-
tal duplication at 6q27. The learning disability, hearing
loss, cardiac and CNS defects observed in the proband,
can be attributed to hemizygous expression of FOXC1,
FOXF2 and GMDS genes on 6p25, and possibly also to
the partial duplication of the distal 6q region. Screening
of r(6) patients for renal pathology is advisable not only
for the medical management of these individuals, but
also to further explore the possible role of FOXC1 gene
in renovascular disease and secondary hypertension.
Despite the genomic associations outlined in the litera-
ture, the correlation with phenotypes and clinical sever-
ity in r(6) cases remains highly variable and complex.
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